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Abstract
Aims To examine the relationship between plasma levels
of the acute-phase proteins ceruloplasmin, alpha-1-antit-
rypsin, orosomucoid, haptoglobin and C-reactive protein
(CRP), and incidence of diabetes in the population-based
Malmo¨ Diet and Cancer Study—Cardiovascular Cohort
(MDCS-CC).
Methods The study population consists of 4246 partici-
pants (aged 46–67 years, 60.8 % women) with no previous
history of diabetes. Participants were followed, and inci-
dence of diabetes was assessed by linkage with national
registers and a clinical re-examination of the cohort. Cox
proportional hazard regression analysis was used to com-
pare incidence of diabetes in relation to sex-specific quar-
tiles of the acute-phase proteins.
Results During a mean follow-up period of
15.6 ± 3.4 years, a total of 390 participants were diag-
nosed with diabetes. Orosomucoid, haptoglobin, and CRP
showed a significant increased risk of diabetes after
adjustment for potential confounders. However, further
adjustments for fasting glucose at baseline resulted in
significant association only for CRP. The multivariable-
adjusted hazard ratios (HR: 4th vs. 1st quartile) were 1.18
(95 % CI: 0.83–1.67; p = 0.51), 1.19 (CI: 0.85–1.62;
p = 0.10), and 1.40 (CI: 1.01–1.95; p = 0.046) for oro-
somucoid, haptoglobin, and CRP respectively.
Conclusion The study demonstrated that there are associ-
ations between orosomucoid, haptoglobin and CRP and the
risk of incidence of diabetes. However, after additional
adjustment for fasting glucose levels at baseline, the
association stayed significant only for CRP.
Keywords Acute-phase proteins  Diabetes  Incidence 
Ceruloplasmin  Alpha-1-antitrypsin  Orosomucoid 
Haptoglobin  CRP
Introduction
Diabetes, a major non-communicable disease, is one of the
foremost public health and development challenges faced
by the world today. The global prevalence of diabetes in
2014 was estimated to be 9 % among adults older than
18 years [1]. The World Health Organization projects that
diabetes will be the seventh leading cause of death in the
world by 2030 [2]. Age, obesity, physical inactivity, and
family history of the disease are the major risk factors for
type 2 diabetes [3].
Chronic low-grade inflammation has also been associ-
ated with the incidence of diabetes [4]. The relationship
between development of diabetes and various inflamma-
tory proteins has been explored in several studies previ-
ously; however, the results have been inconsistent [5–9].
The Women’s Health Study, a prospective study about the
health of middle-aged women in the USA found that ele-
vated level of C-reactive protein (CRP) and interleukin-6
(IL-6) predict development of type 2 diabetes in women
[7]. Plasminogen activator inhibitor-1 (PAI-1) but not fib-
rinogen and CRP were found to predict type 2 diabetes in
the Insulin Resistance Atherosclerosis Study, IRAS [5].
The results from the National Health and Nutrition
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Examination Survey (NHANES) Epidemiologic Follow-up
Study in the USA showed significant association of
leukocyte count with diabetes incidence among women but
not in men; however, erythrocyte sedimentation rate (ESR)
was not associated with diabetes [8]. In another study,
individuals at high risk of type 2 diabetes, using Hemo-
globin A1c (HbA1c) criterion, showed an unfavorable
inflammatory profile of five inflammatory markers (high-
sensitivity hs-CRP, ESR, fibrinogen, white blood cell WBC
count, and complement C3) as compared with control
subjects [10].
Various acute-phase proteins have been associated with
the development of diabetes and impaired glucose toler-
ance. Schmidt et al. studied the association of fibrinogen,
orosomucoid, haptoglobin, and alpha-1-antitrypsin in new
diabetes cases. The results showed strong association of
orosomucoid with incidence of diabetes even when adjus-
ted for different confounders [11]. Another study investi-
gated the association of high levels of a score of five acute-
phase proteins (fibrinogen, orosomucoid, alpha-1-antit-
rypsin, haptoglobin, and ceruloplasmin) with future weight
gain [12]. Elevated levels of acute-phase proteins have
been showed to associate with the prevalence of diabetes
among overweight and obese men in the Malmo¨ Preventive
Project (MPP) [13].
The aim of this prospective study is to investigate the
relationship between plasma levels of five acute-phase
proteins (CRP, ceruloplasmin, alpha-1-antitrypsin, oroso-
mucoid, and haptoglobin) at baseline and incidence of
diabetes in a population-based cohort.
Materials and methods
Study population
The Malmo¨ Diet and Cancer cohort (MDCS) included men
born between 1923 and 1945 and women born between
1923 and 1950. Recruitment was carried out between
March 1991 and September 1996. Out of 74,138 partici-
pants who were invited, a total of 30,447 participants
(60 % women) attended the baseline examinations [14]. A
sub-cohort was obtained from the MDCS by randomly
selecting participants between October 1991 and February
1994, with a primary aim of studying the epidemiology of
carotid artery disease. The sub-cohort consisted of 6103
(2572 men and 3531 women) participants. Out of these,
5540 subjects agreed to give fasting blood samples for
laboratory analysis [15]. Participants lacking data on acute-
phase proteins (n = 858) ceruloplasmin, alpha-1-antit-
rypsin, orosomucoid, and haptoglobin were excluded from
the analysis. For the acute-phase protein CRP, 113 partic-
ipants had missing data. Participants with history of
diabetes (n = 192) at baseline and those with fasting whole
blood glucose of C6.1 mmol/L (n = 359) were also
excluded from the study, hence leaving a final study pop-
ulation of 4246 (see ‘‘Appendix’’ for flowchart).
Baseline examinations
The MDCS baseline measurements comprised of a self-
administered questionnaire, anthropometric measurements,
and collection of blood samples [16]. Non-fasting blood
samples were also drawn which were separated and stored
in the biological bank at -80 C. Information on family
history of diabetes, current use of anti-hypertensive or anti-
diabetic medications, smoking habits, leisure-time physical
activity, educational level, and marital status were obtained
from the questionnaire. Participants were classified into
four categories regarding smoking habits: current smokers,
occasional smokers, ex-smokers, and non-smokers. Low
level of leisure-time physical activity was defined as the
lowest quartile of a score revealed through 18 questions
covering a range of activities in the four seasons [17]. The
measurements of waist circumference (in cm) were carried
out midway between the lowest rib margin and the iliac
crest. Educational level was defined into three categories:
school years\9, 9–12 and[12, respectively [14].
Information on fasting glucose was obtained through
blood samples collected after an overnight fast. Participants
with fasting whole blood glucose of C6.1 mmol/l, which
corresponds to a fasting plasma glucose concentration of
C7.0 mmol/l, as well as those who self-reported diabetes in
the questionnaire or were taking anti-diabetic medication
were classified as diabetics [18]. Blood glucose and HbA1c
were analyzed from fasting blood samples by standardized
procedures at the Department of Clinical Chemistry,
Malmo¨ University hospital. HbA1c was measured by ion
exchange chromatography. The reference values in non-
diabetic individuals were 3.9–5.3 % (19–34 mmol/mol).
Insulin was measured by radioimmunoassay in mIU/l [15].
Measurements of fasting blood glucose and high-density
lipoprotein (HDL) were performed in MDCS-CC on fresh
blood samples according to standard procedures at the
Department of Clinical Chemistry, University Hospital
Malmo¨. Low-density lipoprotein cholesterol (LDL) con-
centration was calculated according to Friedewald’s
formula.
High-sensitive CRP in plasma was analyzed using the
Tina-quant CRP latex assay (Roche Diagnostics, Basel,
Switzerland). Plasma levels of ceruloplasmin, orosomu-
coid, haptoglobin, and alpha-1-antitrypsin were analyzed
using Cobas c-systems (Roche Diagnostics GmbH, Ger-
many). The reference values were 0.15–0.30 g/l for men
and 0.16–0.45 g/l for women for ceruloplasmin [19]. For
alpha-1-antitrypsin, the reference value was 0.9–2.0 g/l
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[19]. The reference value for orosomucoid was 0.5–1.2 g/l
[19]. Finally, the reference value for haptoglobin was
0.3–2.0 g/l (www.roche.com) [19].
Follow-up and endpoint definition
All participants in the study were followed from the
baseline examination until first diagnosis of diabetes,
emigration from Sweden, death or December 31, 2009,
whichever came first. New onset cases of diabetes in the
cohort were gathered from different sources which have
been described in detail previously [20]. To summarize,
incident diabetes was identified by using the Malmo¨
HbA1c register (MHR), the Swedish National Diabetes
Register (NDR), the Swedish inpatient register, the
Swedish outpatient register, the nationwide Swedish drug
prescription register, and the regional Diabetes 2000 reg-
ister of the Ska˚ne region [20, 21]. The cases in the Diabetes
2000 register and NDR were based upon diagnosis by a
physician according to recognized diagnostic criteria
(fasting plasma glucose concentration of C7.0 mmol/l,
measured on two different occasions) [18].
Statistical analysis
CRP was log transformed due to the skewed distribution.
The distribution for ceruloplasmin, haptoglobin, alpha-1-
antitrypsin, and orosomucoid was approximately normal.
Mean values (±standard deviations) and proportions were
used to describe the baseline characteristics of the cohort
for men and women. The acute-phase proteins were cate-
gorized into sex-specific quartiles, i.e., with equal propor-
tion of men and women in each quartile. Linear regression
was used to assess the association between acute-phase
proteins and fasting blood glucose. Cox proportional haz-
ard regression was used to compare the incidence of dia-
betes in different quartiles of individual proteins for the
whole cohort. Hazard ratios (HRs) with 95 % confidence
interval (CI) were calculated. The significance level was
defined as a p value of less than 0.05.
The HRs were adjusted for potential confounders in all
the models. In the first model (Model 1), adjustments were
made for age and sex. The second model (Model 2) was
further adjusted for waist circumference, smoking habits
(current and occasional smokers), physical activity, use of
anti-hypertensive medication, systolic BP, HDL, and edu-
cational level. Finally, additional adjustments were done
for baseline fasting blood glucose in Model 3 to demon-
strate whether the associations were cross-sectional or
prospective. Possible interactions between the plasma
proteins and other risk factors for diabetes were investi-
gated by introducing interaction terms in the multivariable
model. The fit of the proportional hazards model was
confirmed by plotting the incidence rate over time. The
Kaplan–Meier curve was used to illustrate diabetes-free
survival in relation to orosomucoid, haptoglobin, and CRP
in sex-specific quartiles (Figs. 1, 2, 3).
Possible effect modification was assessed by modeling
interaction terms between the acute-phase proteins and age,
sex, and waist circumference, in the adjusted (Model 2)
Cox’s proportional hazards models. All analyses were
performed using IBM SPSS version 22 0 (SPSS Inc.,
Chicago, IL, USA).
Ethical approval was obtained from the Lund University
Ethics Review Committee (LU51/90). All participants gave
written informed consent.
Fig. 1 Diabetes-free survival in relation to sex-specific quartiles
(Q1–Q4) of orosomucoid
Fig. 2 Diabetes-free survival in relation to sex-specific quartiles
(Q1–Q4) of haptoglobin




The baseline characteristics of the study population in
relation to sex have been presented in Table 1. Men and
women were rather similar in terms of baseline character-
istics. Men had slightly higher levels of glucose, waist
circumference, and higher blood pressure and used more
anti-hypertensive medications. Women had higher cerulo-
plasmin levels than men.
Correlations between acute-phase proteins
and glucose
Ceruloplasmin, orosomucoid, haptoglobin, and CRP
showed significant and positive correlations with fasting
glucose, after adjustment for age and sex as shown in
Table 2. This association remained statistically significant
for orosomucoid and haptoglobin after further adjustment
for the other covariates.
Incidence of diabetes in relation to acute-phase
proteins
The mean follow-up period was 15.6 ± 3.4 years. A total
of 390 participants (181 men and 209 women) were diag-
nosed with diabetes during the follow-up period. The
incidence of diabetes was 7.19 per 1000 person-years in
men and 5.09 per 1000 person-years in women.
Of the five acute-phase proteins, subjects in the fourth
compared to the first quartile of orosomucoid, haptoglobin
and CRP, respectively, had significantly higher risk of
incidence of diabetes in the first model (Table 3). Fig-
ures 1, 2, and 3 illustrate the diabetes-free survival by
quartiles of these acute-phase proteins. After adjustment
for covariates in Model 2, this risk increase remained for
orosomucoid (HR 1.46; 95 % CI 1.03–2.08), haptoglobin
(HR 1.49; 95 % CI 1.08–2.05), and CRP (HR 1.44; 95 %
CI 1.03–2.00). However, after also taking fasting blood
glucose into account in Model 3, only CRP remained sig-
nificant (HR 1.40; 95 % CI 1.01–1.95; Table 3).
Fig. 3 Diabetes-free survival in relation to sex-specific quartiles
(Q1–Q4) of CRP
Table 1 Baseline
characteristics of the MDCS-CC
among men and women
(N = 4246)
Baseline characteristics Men Women
N 1664 2582
Incidence of diabetes n (n per 1000 p-y) 181 (7.19) 209 (5.09)
Glucose (mmol/l) 5.01 ± 0.4 4.80 ± 0.4
Age at baseline (years) 57.63 ± 6.0 57.39 ± .5.9
Ceruloplasmin (mg/l) 0.46 ± 0.10 0.54 ± 0.12
Alpha-1-antitrypsin (mg/l) 1.19 ± 0.26 1.21 ± 0.26
Orosomucoid (mg/l) 0.71 ± 0.21 0.69 ± 0.20
Haptoglobin (mg/l) 1.30 ± 0.58 1.31 ± 0.51
CRP (mg/l) (GM [5th–95th percentiles]) 1.35 (0.30–8.30) 1.29 (0.30–7.21)
Waist circumference (cm) 92.15 ± 9.4 76.18 ± 9.5
Low physical activity (%) 20.9 22.4
Current smoking status (%, current and occasional smokers) 26.1 25.6
Use of anti-hypertensive medication (%) 15.0 13.3
Systolic BP (mmHg) 142.4 ± 18.5 139.2 ± 18.9
HDL (mmol/l) 1.23 ± 0.30 1.53 ± 0.35
Low educational level (%) 46.4 43.3
Data are mean ± SD unless otherwise indicated
p-y person year
984 Acta Diabetol (2016) 53:981–989
123
There was a significant interaction between orosomu-
coid and waist (p = 0.009) when checked for effect mod-
ification, indicating a lower effect of orosomucoid in
subjects with high waist circumference. No significant
interaction was observed between the other acute-phase
proteins, and age, sex, and waist in the adjusted model
(Model 2).
Discussion
Low-grade inflammation has been associated with the
incidence of diabetes [4–10]. However, the results from
previous studies have been inconsistent and different for
different inflammatory markers. The present study revealed
significant associations between the acute-phase proteins
orosomucoid, haptoglobin, and CRP and increased inci-
dence of diabetes when adjusted for several potential
confounders. However, after additional adjustment for
fasting glucose, only CRP remained significantly associ-
ated with incident diabetes.
The results are in accordance with a study from the
Malmo¨ Preventive Project, which reported nonsignificant
relationships for ceruloplasmin, alpha-1-antitrypsin, hap-
toglobin and orosomucoid and incident diabetes after
adjustments for fasting glucose and other risk factors [22].
The association of orosomucoid seen in our study is in
contrast to the findings of Schmidt et al. [11], who found an
association between orosomucoid and diabetes after
adjustment for several potential confounders including
glucose. Similar to our study, no relation was found for
alpha-1-antitrypsin and haptoglobin with diabetes. How-
ever, we found cross-sectional significant correlations
between glucose and haptoglobin and orosomucoid,
respectively. This is in accordance with findings from a
case-control study by McMillan, which showed increased
levels of haptoglobin, orosomucoid, and CRP in
association with diabetes and glucose intolerance [6].
Ceruloplasmin and alpha-1-antitrypsin were less markedly
raised in participants with diabetes [6].
Many studies have shown association between CRP and
type 2 diabetes [6]. A prospective analysis and meta-
analysis conducted by Lee et al. [23] showed that there is
evidence of association between CRP and incidence of
diabetes. However, these results were explained by central
adiposity and markers of liver dysfunction. The meta-
analysis demonstrated an overall relationship between CRP
and diabetes, but there was a substantial heterogeneity in
the results between studies, which reduced the degree of
evidence in the meta-analysis [23]. A retrospective study
conducted in a Japanese health screening population, where
obesity was not prevalent, showed that hs-CRP, but not
WBC, was independently associated with incident diabetes
[24]. In the present population-based study, the results were
controlled for confounders including waist circumference
and baseline glucose levels and showed significant asso-
ciation in results.
It is widely accepted that systemic low-grade inflam-
mation is associated with diabetes. However, inflamma-
tion is a heterogeneous concept, and the association
between different inflammatory markers is often moder-
ate. Interleukin (IL)-6, IL-1beta, and tumor necrosis fac-
tor-alpha (TNF-a) are important regulators of the hepatic
production of acute-phase proteins [25, 26], but the reg-
ulation of the acute-phase protein production is very
complex. Different cytokines operate in a network which
results in additive, inhibitory, or synergistic regulatory
effects of the production of different acute-phase proteins,
depending on presence or absence of other cytokines and
transcription factors, such as STAT3 or NF-jB [25].
Previous studies regarding the association between
inflammation and incidence of diabetes have reported
varying results for different inflammatory markers [5–9].
The varying relationships with incidence of diabetes
could hypothetically be explained by differences with
respect to the cytokines and transcription factors that
regulate their production.
Dandona et al. [27] suggested two possible mechanisms
involved in the pathogenesis of inflammation, and its link
to obesity and diabetes. They proposed that firstly, chronic
over-nutrition (causing obesity) can lead to a state of
oxidative stress and hence inflammatory changes. Sec-
ondly, increased concentration of the pro-inflammatory
cytokines such as TNF-a and IL-6 associated with obesity
and diabetes might impair insulin action by suppressing
insulin signal transduction [27]. The link between pro-in-
flammatory cytokines and insulin action was demonstrated
by Hotamisligil et al., who showed increased expression of
TNF-a in adipose tissue of obese rodents. A significantly
increased peripheral uptake of glucose was observed in
Table 2 Correlations between acute-phase proteins and glucose in
non-diabetic individuals






Values are standardized beta coefficients, from a linear regression
model with the acute-phase protein as the dependent variable
* p\ 0.05; ** p\ 0.01; *** p\ 0.001
a Risk factors: adjusted for age, sex, waist circumference, smoking,
use of anti-hypertensive medication, systolic BP, HDL, low educa-
tional level, and low physical activity
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response to insulin when TNF-a was neutralized in obese
fa/fa rats [28]. It was further demonstrated that TNF-a
induces insulin resistance though an inhibitory form of
insulin receptor substrate 1 [29]. Dandona et al. [30]
established the association of higher serum TNF-a con-
centrations with obesity and significant fall in the levels
with weight loss. In addition, it has been shown that a
single high-fat high-calorie meal results in inflammation
with increased expression of NFkB and many pro-inflam-
matory cytokines, including TNF-a [31, 32] which sug-
gests that dietary factors could be a common link between
inflammation and diabetes.
Table 3 Incidence of diabetes in relation to sex-specific quartiles of five acute-phase proteins
Q1 Q2 Q3 Q4 p for trend
Ceruloplasmin
Mean ± SD 0.39 ± 0.050 0.47 ± 0.048 0.52 ± 0.046 0.65 ± 0.112
Incidence of diabetes
n (n/1000)a
74 (4.4) 104 (6.3) 111 (6.9) 101 (6.0)
Model 1 1 1.41 (1.05–1.90) 1.52 (1.13–2.04) 1.32 (0.98–1.79) 0.074
Model 2 1 1.29 (0.95–1.77) 1.33 (0.97–1.80) 1.09 (0.79–1.49) 0.739
Model 3 1 1.25 (0.92–1.71) 1.36 (1.00–1.85) 1.06 (0.78–1.46) 0.748
Alpha-1-antitrypsin
Mean ± SD 0.88 ± 0.157 1.14 ± 0.049 1.27 ± 0.047 1.55 ± 0.197
Incidence of diabetes
n (n/1000)a
82 (5.3) 119 (5.6) 101 (6.7) 88 (6.1)
Model 1 1 1.10 (0.83–1.46) 1.21 (0.90–1.62) 1.19 (0.88–1.61) 0.191
Model 2 1 1.20 (0.89–1.61) 1.20 (0.88–1.64) 1.18 (0.85–1.62) 0.374
Model 3 1 1.27 (0.94–1.71) 1.32 (0.97–1.81) 1.27 (0.91–1.75) 0.153
Orosomucoid
Mean ± SD 0.46 ± 0.059 0.60 ± 0.000 0.74 ± 0.050 1.10 ± 0.163
Incidence of diabetes
n (n/1000)a
53 (3.3) 79 (5.5) 152 (6.6) 106 (8.4)
Model 1 1 1.66 (1.17–2.35) 1.99 (1.45–2.71) 2.52 (1.81–3.50) \0.001
Model 2 1 1.30 (0.91–1.87) 1.25 (0.90–1.74) 1.46 (1.03–2.08) 0.058
Model 3 1 1.16 (0.81–1.67) 1.06 (0.76–1.48) 1.18 (0.83–1.67) 0.510
Haptoglobin
Mean ± SD 0.68 ± 0.182 1.07 ± 0.099 1.44 ± 0.110 2.05 ± 0.410
Incidence of diabetes
n (n/1000)a
66 (4.1) 79 (4.5) 126 (7.0) 119 (8.2)
Model 1 1 1.07 (0.77–1.48) 1.70 (1.26–2.29) 2.06 (1.52–2.78) \0.001
Model 2 1 1.00 (0.71–1.40) 1.40 (1.03–1.92) 1.49 (1.08–2.05) 0.002
Model 3 1 0.91 (0.65–1.28) 1.23 (0.90–1.67) 1.19 (0.85–1.62) 0.100
CRP
Mean ± SD 0.41 ± 0.149 0.92 ± 0.170 1.81 ± 0.380 6.44 ± 6.714
Incidence of diabetes
n (n/1000)a
63 (3.7) 72 (4.6) 104 (6.4) 143 (9.3)
Model 1 1 1.24 (0.89–1.74) 1.72 (1.26–2.36) 2.59 (1.93–3.49) \0.001
Model 2 1 1.10 (0.78–1.56) 1.17 (0.84–1.64) 1.44 (1.03–2.00) 0.023
Model 3 1 1.24 (0.87–1.76) 1.28 (0.92–1.79) 1.40 (1.01–1.95) 0.046
Model 1: Adjusted for age and sex
Model 2: Adjusted for age, sex, waist circumference, smoking, use of anti-hypertensive medication, systolic BP, HDL, low educational level, and
low physical activity at baseline
Model 3: Adjusted for age, sex, waist circumference, smoking, use of anti-hypertensive medication, systolic BP, HDL, low educational level, low
physical activity, and fasting glucose at baseline
a Number of cases (incidence per 1000 person-years)
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Many studies have shown associations between obesity,
acute-phase proteins and diabetes [33, 34]. It can be argued
that the link between inflammation and diabetes can be
explained by the presence of obesity and adipose tissue
which itself is a source of low-grade inflammation. How-
ever, this study has taken this fact into consideration, and
the analysis has been adjusted for waist circumference. As
the association is still significant, it can be speculated that
there is a potential mechanism directly relating diabetes
and inflammation. It should, however, be considered that
previously it had been demonstrated that the association
between CRP and diabetes is more likely to be non-casual,
shown in the study by Brunner et al. [35]. Mendelian
randomization was used in the study to demonstrate that
the risk of developing diabetes was not associated with
CRP levels in the European population. However, Brunner
et al. [35] did not rule out the fact that acute-phase proteins
early in the inflammatory process might be related to the
development of diabetes.
Strengths and limitations
The data used for this study is derived from a large-scale
population-based cohort with a participation rate of 41 %
[14]. The low participation rate stresses the importance to
highlight the differences between the participants and non-
participants in order to assess the external validity of the
findings. Non-participants showed higher mortality than
participants during and after the recruitment period, as well
as during the follow-up. The participants in the MDCS
were also compared to participants who took part in a
mailed health survey (participation rate 75 %) in the same
population. The participants of the cohort study showed
comparatively better health but were still representative of
the population in terms of socioeconomic structure,
smoking habits, and obesity [14].
One advantage of the prospective design is that it
enables the collection of information on exposure variables
before onset of disease, which decreases potential recall
bias and risk of reverse causation. The large sample size
and long follow-up period enable detection of a large
number of endpoint cases. Moreover, information about
endpoints for this study was retrieved from various national
registers and several data sources as mentioned earlier and
has high validity [36]. Although multiple sources were
used to ensure detection of all endpoint cases, it should be
taken into account that diabetes can go undetected for a
long time, and participants who did not seek medical
attention might have been missed.
Some methodological issues need to be considered.
Since this is an observational study, confounding is a main
concern. Adequate adjustment for probable confounders
was carried out in the Cox regression models. Although the
analysis was adjusted for several possible confounders, the
possibility of residual confounding cannot be ruled out.
Another limitation of the study is that the plasma levels
of the acute-phase proteins were measured only at the
baseline. The levels may have changed over time before
the incidence of the disease. Similarly, anthropometric
measurements were also carried out during the baseline
visits and might have changed over the study period. One
more limitation of this study is regarding the information
on the type of diabetes. As the study cohort consists of
middle-aged subjects, it can be assumed that almost all
cases developed type 2 diabetes, as type 1 diabetes most
often manifests at a younger age, and therefore were
excluded as prevalent diabetes at baseline [37]. Another
point to consider is that the cohort included participants
being residents of Malmo¨, Sweden, only. However, based
on previous reports by McMillan [6], Schmidt et al. [11],
and Lee [23], it seems likely that the results can be gen-
eralized to other populations as well.
Conclusion
In conclusion, this study demonstrated that there are
associations between orosomucoid, haptoglobin, and CRP
and the risk of incident diabetes. However, after additional
adjustment for glucose, the association stayed significant
for CRP. Further research in this regard is required to
elucidate the underlying mechanism.
Acknowledgments The study was supported by the Swedish
Research Council (Grant No. 2014-2265) and the Swedish Heart–
Lung Foundation (Grant No. 2013-0249). We would like to
acknowledge the information provided by the Nordic Diabetes
Register, the Malmo¨ HbA1c register, the Diabetes register 2000, and
the registers provided by the Swedish Board of Health and Welfare.
Compliance with ethical standards
Conflict of interest The authors declare that they have no conflict of
interest.
Ethical standard All procedures performed in this study involving
human participants were in accordance with the ethical standards of
the Lund University Ethics Review Committee and with the 1964
Declaration of Helsinki and its later amendments.
Human and animal rights disclosure The study was conducted in
accordance with the principles of the Declaration of Helsinki of 1975,
as revised in 2008.
Informed consent Informed consent was obtained from all individ-
ual participants included in the study.
Open Access This article is distributed under the terms of the
Creative Commons Attribution 4.0 International License (http://crea
tivecommons.org/licenses/by/4.0/), which permits unrestricted use,
distribution, and reproduction in any medium, provided you give
Acta Diabetol (2016) 53:981–989 987
123
appropriate credit to the original author(s) and the source, provide a





1. World Health Organization (2014) Global status report on non-
communicable diseases. Available at: http://apps.who.int/iris/bit
stream/10665/148114/1/9789241564854_eng.pdf?ua=1. Acces-
sed 1 Jun 2016
2. Mathers CD, Loncar D (2006) Projections of global mortality and
burden of disease from 2002 to 2030. PLoS Med 3(11):e442
3. Fletcher B, Gulanick M, Lamendola C (2002) Risk factors for
type 2 diabetes mellitus. J Cardiovasc Nurs 16(2):17–23
4. Pickup JC (2004) Inflammation and activated innate immunity in
the pathogenesis of type 2 diabetes. Diabetes Care 27(3):813–823
5. Festa A, D’Agostino R Jr, Tracy RP, Haffner SM, Insulin
Resistance Atherosclerosis Study (2002) Elevated levels of acute-
phase proteins and plasminogen activator inhibitor-1 predict the
development of type 2 diabetes: the insulin resistance
atherosclerosis study. Diabetes 51(4):1131–1137
6. McMillan DE (1989) Increased levels of acute-phase serum
proteins in diabetes. Metabolism 38(11):1042–1046
7. Pradhan AD, Manson JE, Rifai N, Buring JE, Ridker PM (2001)
C-reactive protein, interleukin 6, and risk of developing type 2
diabetes mellitus. JAMA 286(3):327–334
8. Ford ES (2002) Leukocyte count, erythrocyte sedimentation rate,
and diabetes incidence in a national sample of US adults. Am J
Epidemiol 155(1):57–64
9. Ganrot PO, Gydell K, Ekelund H (1967) Serum concentration
of alpha-2-macroglobulin, haptoglobin and alpha-1-antit-
rypsin in diabetes mellitus. Acta Endocrinol (Copenh)
55(3):537–544
10. Fiorentino TV, Hribal ML, Perticone M et al (2015) Unfavorable
inflammatory profile in adults at risk of type 2 diabetes identified
by hemoglobin A1c levels according to the American Diabetes
Association criteria. Acta Diabetol 52(2):349–356
11. Schmidt MI, Duncan BB, Sharrett AR et al (1999) Markers of
inflammation and prediction of diabetes mellitus in adults
(Atherosclerosis Risk in Communities study): a cohort study.
Lancet 353(9165):1649–1652
12. Engstrom G, Hedblad B, Stavenow L, Lind P, Janzon L, Lind-
garde F (2003) Inflammation-sensitive plasma proteins are asso-
ciated with future weight gain. Diabetes 52(8):2097–2101
13. Engstrom G, Stavenow L, Hedblad B et al (2003) Inflammation-
sensitive plasma proteins, diabetes, and mortality and incidence
of myocardial infarction and stroke: a population-based study.
Diabetes 52(2):442–447
14. Manjer J, Carlsson S, Elmstahl S et al (2001) The Malmo Diet
and Cancer Study: representativity, cancer incidence and mor-
tality in participants and non-participants. Eur J Cancer Prev
10(6):489–499
15. Hedblad B, Nilsson P, Janzon L, Berglund G (2000) Relation
between insulin resistance and carotid intima-media thickness
and stenosis in non-diabetic subjects. Results from a cross-sec-
tional study in Malmo, Sweden. Diabetes Med 17(4):299–307
16. Berglund G, Elmstahl S, Janzon L, Larsson SA, The Malmo Diet
and Cancer Study (1993) Design and feasibility. J Intern Med
233(1):45–51
17. Li C, Aronsson CA, Hedblad B, Gullberg B, Wirfalt E, Berglund
G (2009) Ability of physical activity measurements to assess
health-related risks. Eur J Clin Nutr 63(12):1448–1451
18. Expert Committee on the Diagnosis and Classification of Dia-
betes Mellitus (2003) Report of the expert committee on the
diagnosis and classification of diabetes mellitus. Diabetes Care
26(Suppl 1):S5–S20
19. Konsensuswerte der Deutschen Gesellschaft fu¨r Laboratori-
umsmedizin, der Deutschen Gesellschaft fu¨r Klinische Chemie
und des Verbandes der Diagnostica-Industrie e.V. (VDGH)
(1995) DG Klinische Chemie Mitteilungen 26:119–122
20. Enhorning S, Wang TJ, Nilsson PM et al (2010) Plasma copeptin
and the risk of diabetes mellitus. Circulation 121(19):2102–2108
21. Melander O, Maisel AS, Almgren P et al (2012) Plasma
proneurotensin and incidence of diabetes, cardiovascular disease,
breast cancer, and mortality. JAMA 308(14):1469–1475
22. Engstrom G, Hedblad B, Eriksson KF, Janzon L, Lindgarde F
(2005) Complement C3 is a risk factor for the development of
diabetes: a population-based cohort study. Diabetes
54(2):570–575
23. Lee CC, Adler AI, Sandhu MS et al (2009) Association of
C-reactive protein with type 2 diabetes: prospective analysis and
meta-analysis. Diabetologia 52(6):1040–1047
24. Oda E (2015) High-sensitivity C-reactive protein, but not white
blood cell count, independently predicted incident diabetes in a
Japanese health screening population. Acta Diabetol
52(5):983–990
25. Bode JG, Albrecht U, Haussinger D, Heinrich PC, Schaper F
(2012) Hepatic acute phase proteins—regulation by IL-6- and IL-
1-type cytokines involving STAT3 and its crosstalk with NF-
kappaB-dependent signaling. Eur J Cell Biol 91(6–7):496–505
26. Moshage H (1997) Cytokines and the hepatic acute phase
response. J Pathol 181(3):257–266
MDC – Cardiovascular cohort (MDC-CC):
Recruitment period: October 1991 to February 1994
n=6103(M=2572, F=3531)
Malmo Diet and Cancer Cohort (MDC):
Recruitment period: January 1991 to September 1996
n=30,447 (M=12,121 F=18,326)ref 13
Number of parcipants in MDC-CC who accepted invitaons 
for fasng blood samples 
n=5540 ref 14
Number of parcipants with available data on acute 
phase proteins and with no history of diabetes and fasng 
whole blood glucose of <6.1 mmol/L at baseline
n=4246
Fig. 4 Flow chart
988 Acta Diabetol (2016) 53:981–989
123
27. Dandona P, Aljada A, Bandyopadhyay A (2004) Inflammation:
the link between insulin resistance, obesity and diabetes. Trends
Immunol 25(1):4–7
28. Hotamisligil GS, Shargill NS, Spiegelman BM (1993) Adipose
expression of tumor necrosis factor-alpha: direct role in obesity-
linked insulin resistance. Science 259(5091):87–91
29. Hotamisligil GS, Peraldi P, Budavari A, Ellis R, White MF,
Spiegelman BM (1996) IRS-1-mediated inhibition of insulin
receptor tyrosine kinase activity in TNF-alpha- and obesity-in-
duced insulin resistance. Science 271(5249):665–668
30. Dandona P, Weinstock R, Thusu K, Abdel-Rahman E, Aljada A,
Wadden T (1998) Tumor necrosis factor-alpha in sera of obese
patients: fall with weight loss. J Clin Endocrinol Metab
83(8):2907–2910
31. Ghanim H, Abuaysheh S, Sia CL et al (2009) Increase in plasma
endotoxin concentrations and the expression of Toll-like recep-
tors and suppressor of cytokine signaling-3 in mononuclear cells
after a high-fat, high-carbohydrate meal: implications for insulin
resistance. Diabetes Care 32(12):2281–2287
32. Fogarty CL, Nieminen JK, Peraneva L et al (2015) High-fat
meals induce systemic cytokine release without evidence of
endotoxemia-mediated cytokine production from circulating
monocytes or myeloid dendritic cells. Acta Diabetol
52(2):315–322
33. Hotamisligil GS (1999) The role of TNFalpha and TNF receptors
in obesity and insulin resistance. J Intern Med 245(6):621–625
34. Yudkin JS, Stehouwer CD, Emeis JJ, Coppack SW (1999)
C-reactive protein in healthy subjects: associations with obesity,
insulin resistance, and endothelial dysfunction: a potential role
for cytokines originating from adipose tissue? Arterioscler
Thromb Vasc Biol 19(4):972–978
35. Brunner EJ, Kivimaki M, Witte DR et al (2008) Inflammation,
insulin resistance, and diabetes–Mendelian randomization using
CRP haplotypes points upstream. PLoS Med 5(8):e155
36. Ludvigsson JF, Andersson E, Ekbom A et al (2011) External
review and validation of the Swedish national inpatient register.
BMC Public Health 11:450
37. Maahs DM, West NA, Lawrence JM, Mayer-Davis EJ (2010)
Epidemiology of type 1 diabetes. Endocrinol Metab Clin N Am
39(3):481–497
Acta Diabetol (2016) 53:981–989 989
123
